Recommendations of the National Advisory Committee on Immunization (NACI) on the use of the Pfizer-BioNTech COVID-19 vaccine
Organization: Public Health Agency of Canada (PHAC)Published: 2020
"This webinar is to inform health care providers on the NACI recommendations on the use of this COVID-19 vaccine." - Recommendations of the National Advisory Committee on Immunization (NACI) on the use of the Pfizer-BioNTech COVID-19 vaccine
Resource Group:
Implementation Tool
Product Type: Webinar
Research and Development
Program Delivery and Evaluation
Vaccine Management
Sub Topics: Vaccine Safety and Development
Clinics
Vaccine Safety
Storage and Handling
Allocation and Distribution
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Webinar
Category:
Program Planning and Delivery,Research and Development,Program Delivery and Evaluation,Vaccine Management,Sub Topics: Vaccine Safety and Development,Clinics,Vaccine Safety,Storage and Handling,Allocation and Distribution,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and DeliveryResearch and Development
Program Delivery and Evaluation
Vaccine Management
Sub Topics: Vaccine Safety and Development
Clinics
Vaccine Safety
Storage and Handling
Allocation and Distribution
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Audience:
Health Care Professional
Population: Seniors
High Risk Adults
Indigenous Populations
Healthcare Personnel
Region: National
Population: Seniors
High Risk Adults
Indigenous Populations
Healthcare Personnel
Region: National
Language:
English
Link
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.